Abdominal Obesity & Metabolic Syndrome: Why It Matters for Health and Law
- Rick Miller
- Mar 20, 2024
- 4 min read
Updated: Mar 17
What is abdominal obesity and why does it increase health risks?
Abdominal obesity refers to excess visceral fat around the organs, typically identified by an increased waist circumference. It is a key component of metabolic syndrome, a cluster of metabolic risk factors including insulin resistance, hypertension, and abnormal cholesterol levels.
When abdominal obesity and metabolic syndrome are not identified or acted upon in clinical practice, opportunities for prevention may be missed. In some circumstances, failure to recognise or manage these risks can become relevant in clinical negligence or medico-legal cases.

Introduction
Not all fat is created equal.
The weight carried around the abdomen - often called central or visceral fat - carries a far greater metabolic risk than fat stored elsewhere in the body.
Unlike subcutaneous fat (the fat under the skin), visceral fat surrounds the organs and behaves differently at a biological level. It releases inflammatory chemicals and hormones that disrupt metabolism and increase cardiovascular risk.
As a dietitian, I frequently see patients who are surprised when blood tests reveal metabolic risk despite appearing relatively healthy externally.
As an expert witness, I have also reviewed cases where failure to recognise abdominal obesity or metabolic syndrome contributed to preventable harm.
What Is Abdominal Obesity?
Abdominal obesity is usually assessed using waist circumference.
Typical clinical thresholds include:
Men: waist circumference greater than 94 cm
Women: waist circumference greater than 80 cm
These measurements are used because waist circumference correlates strongly with visceral fat accumulation.
Visceral Fat vs Subcutaneous Fat
Visceral fat:
surrounds internal organs
produces inflammatory cytokines
increases insulin resistance
contributes to cardiovascular disease
Subcutaneous fat:
sits beneath the skin
is less metabolically active
carries lower systemic risk
For this reason, two people with the same body weight may have very different metabolic risk profiles.
What Is Metabolic Syndrome?
Metabolic syndrome describes a cluster of metabolic abnormalities that increase the risk of cardiovascular disease and type 2 diabetes.
A diagnosis is typically made when three or more of the following factors are present:
central obesity
elevated blood pressure
raised fasting glucose or insulin resistance
elevated triglycerides
low HDL cholesterol
Why Metabolic Syndrome Matters
Metabolic syndrome significantly increases long-term health risks.
Research consistently shows:
five-fold increased risk of type 2 diabetes
two-fold increased risk of cardiovascular disease
increased risk of fatty liver disease, kidney disease and cognitive decline
For clinicians, identifying these markers early provides a major opportunity for prevention.
The Clinical Role of Dietitians
Dietitians play an important role in identifying and managing metabolic risk.
Typical assessments include:
BMI and waist circumference measurement
review of blood markers such as glucose, lipids and liver function
dietary assessment and lifestyle evaluation
Nutrition Interventions
Evidence-based nutrition strategies often include:
Mediterranean-style dietary patterns
increased fibre intake
reduction in refined carbohydrates
increased omega-3 intake
structured weight loss interventions
When applied early, these interventions can significantly reduce cardiometabolic risk.
Abdominal Obesity in the Medico-Legal Context
Abdominal obesity is not simply a cosmetic issue.
In some clinical negligence cases, it becomes relevant where clear metabolic risk factors were present but not acted upon.
Potential medico-legal issues may include:
failure to assess waist circumference in high-risk patients
lack of screening for metabolic syndrome or diabetes
missed opportunities for prevention in primary care
failure to investigate abnormal metabolic markers
Case Example
In one case I reviewed, a middle-aged patient presented repeatedly with hypertension and a markedly elevated waist circumference.
Despite these risk indicators, screening for diabetes was not performed.
The patient later suffered a stroke related to uncontrolled metabolic disease.
During litigation, the failure to recognise and act on metabolic syndrome indicators became a key issue in the claim.
Can You Be Normal Weight and Still Have Metabolic Syndrome?
Yes.
Some individuals appear relatively lean but still carry significant visceral fat.
This phenomenon is often described as TOFI — “Thin Outside, Fat Inside.”
These individuals may have:
normal BMI
elevated visceral fat
insulin resistance
abnormal lipid profiles
Without metabolic screening, these risks may go undetected.
Is Metabolic Syndrome Reversible?
In many cases, yes.
Lifestyle interventions can significantly improve metabolic markers.
Key interventions include:
weight reduction
improved dietary quality
increased physical activity
improved sleep and stress management
When addressed early, metabolic syndrome can often be reversed or significantly improved.
Why Metabolic Risk Factors Matter in Clinical Negligence
From a medico-legal perspective, the key issue is not simply whether risk factors were present.
The question becomes whether reasonable clinical care required that those risks be recognised and acted upon.
Failure to identify metabolic syndrome may lead to:
missed opportunities for prevention
delayed diagnosis of diabetes
avoidable cardiovascular complications



Comments